Secures Final USFDA Approval for Methotrexate Injection
Alembic Pharmaceuticals Ltd · APLLTD · BSE ·
Alembic has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Methotrexate Injection USP. The drug is indicated for treating various neoplastic diseases (like breast cancer), rheumatoid arthritis, and severe…